TechConnect Innovation Program

Ondansetron, a 5-HT3 receptor antagonist reduces major depression episodes exacerbated by nanoparticles intoxication

Uppsala University, Uppland, Sweden

TECHNOLOGY SUMMARY

Major depression (MD) in our military deployment is more prevalent in young women (18-25 age group) that could be exacerbated by nanoparticles (NPs) SiO2 and carbon exposure. We found that TiO2 nanowired ondansetron markedly reduces MD episodes in model experiments in female rats in such situations for the 1st time.

Primary Application Area: Biotech & Biological Sciences

Technology Development Status: Concept

Technology Readiness Level:

FIGURES OF MERIT

Value Proposition:

SHOWCASE SUMMARY

Organization Type: Academic/Gov Lab

Showcase Booth #: 636

Website: www.uu.se

GOVT/EXTERNAL FUNDING SOURCES

Government Funding/Support to Date: